Does an allergy to fish pre-empt an adverse protamine reaction? A case report and a literature review

Abstract

The operating theatre exposes patients to myriad potential agents which could result in a life-threatening anaphylactic reaction. Anaesthetic drugs, blood products, and latex are only some of the possible allergens. Reactions are deemed to be anaphylactic when immediate sensitivity is combined with cardiovascular collapse. A patient who had a known allergy to shellfish presented for first time cardiopulmonary bypass. The perfusion team were concerned that there was a realistic possibility that an adverse reaction to protamine could occur. Anaphylactic reactions to protamine in patients allergic to fish have been reported. The anaesthetic team were informed and the necessary precautions taken. We report on the outcome for our patient and also discuss other risk factors and the types of reactions that can result when an adverse reaction to protamine occurs.

Get full access to this article

View all access options for this article.

References

1 Levy JH Schweiger IM Zaidan JR . Evaluation of patients at risk for protamine reactions. J Thorac Cariovasc Surg 1989; 98: 200–204.

2 Nybo M Madsen JS . Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic & Clinical Pharmacology & Toxicology 2008; 103: 192–196.

3 Panos A Orrit X Chevalley C Kalangos A . Dramatic post-cardiotomy outcome, due to severe anaphylactic reaction to protamine. Eur J Cardiothorac Surg 2003; 24: 325–327.

4 Lowenstein E Johnston WE Lappas DG . Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology 1983; 59: 470–473.

5 Conzen P Habazettl H Gutmann R . Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs. Anesth Analg 1989; 68: 25–31.

6 Knape JTA Schuller JL de Haan P . An anaphylactic reaction to protamine in a patient allergic to fish. Aneasthesiology 1981; 55: 324–325.

7 Kurtz AB Gray RS Markanday S Nabarro JD . Circulating IgG antibody to protamine in patients treated with protamine-insulins. Diabetologia 1983; 25: 322–324.

8 Sharath MD Metzger WJ Richerson HB . Protamine-induced fatal anaphylaxis: prevalence of antiprotamine immunoglobulin E antibody. J Thorac Cardiovasc Surg 1985; 90: 86–90.

9 Roelofse JA van der Bijl P . An anaphylactic reaction to protamine sulphate. Anesth Prog. 1991; 38(3): 99–100.

10.

10 Adourian U Shampaine EL Hirshman CA . High-titre protamine specific IgG antibody associated with anaphylaxis: report of a case and quantitive analysis of antibody in vasectomized men. Anesthesiology 1993; 78: 368–372.

11.

11 Weiss ME Nyhan D Peng ZK . Association of protamine IgG and IgE antibodies with life threatening reactions to intravenous protamine. N Engl J Med 1989; 320: 886–892.

12.

12 Vasquez JC Vichiendilokkul A Mahmood S Baciewicz FA . Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery. Ann Thorac Surg 2002; 74: 2177–2179.

13.

13 Stafford-Smith M Lefrak EA Newman MF . Efficacy and safety of heparinase1 versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass. Anesthesiology 2005; 103(2): 229–240.

14.

14 Kikura M Lee MK Levy JH . Heparin neutralization with Methylene Blue, Hexadimethrine, or Vancomycin after cardiopulmonary bypass. Anesth Analg 1996; 83: 223–227.

15.

15 John M . Weiler, MD, Melanie, A, et al. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery. J Allergy Clin Immunol 1990; 85(4): 713–719.

16.

16 Kimmel SE Sekeres MA Berlin JA Ellison N DiSesa V Strom BL . Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass. J Am Coll Cardiol 1998; 32: 1916–1922.

17.

17 Kimmel SE Sekeres MA Berlin JA Ellison N . Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass. Anesth Analg 2002; 94: 1402–1408.

18.

18 Borowiec J Thelin S Bagge L van der Linden J Thorno E Hansson HE . Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery – a clinical study. Ups J Med Sci 1992; 97(1): 55–66.

19.

19 Mukadam ME Pritchard P . Riddlington, D, et al. Management during CPB of patients with presumed fish allergy. Cardiothorac Vasc Anesth 2001; 15(4): 512–519.